Previous 10 | Next 10 |
Zynex faces at least 12 contentious issues that reveal troubling fundamentals. The business model is not sustainable for the long term. The shares are grossly overvalued based on DCF, Discount EPS, and Reverse DCF and Reverse EPS valuation models. Until ethical concerns and th...
Insiders own ~8.1% of the 139.41M shares outstanding. The CEO and 2 Directors purchased shares in the open market from 11-Aug-2021 to 16-Aug-2021. Holo Surgical platform approval expected in Q4 2021 with an 85% likelihood. For further details see: Surgalign Holdings: Ins...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips No doubt, a strong portfolio typically includes stocks with robust fundamentals and solid track records. In a bull market, these investments provide healthy returns and protect against capital erosion. However, we should no...
Gainers: Trillium Therapeutics (NASDAQ:TRIL) +187%, Vivos Therapeutics (NASDAQ:VVOS) +57%, Xeris Pharmaceuticals (NASDAQ:XERS) +19%, ALX Oncology (NASDAQ:ALXO) +24%, Candel Therapeutics (NASDAQ:CADL) +20%. Losers: Flora Growth (NASDAQ:FLGC) -10%,...
DEERFIELD, Ill., Aug. 19, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that the United States Patent and Trademark Office (USPTO) r...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Surgalign Holdings (NASDAQ: SRGA ) stock is on the move Monday following news of the company’s CEO buying up shares of SRGA. Source: Shutterstock This news comes from filings with the U.S. Securities an...
Insiders Are Scooping Up Shares Of These Penny Stocks Right Now Trying to track down the best penny stocks to buy right now ? Some traders will focus on technical indicators and charts. Others may look for news headlines or earnings reports. There’s another train of thoug...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! It’s been a while but we’re back at it with a look at the biggest pre-market stock movers for Monday. Source: f11photo/Shutterstock.com But before that, take a quick second to c...
SRGA (a medical device company in spine and digital surgery) is trading like an underfollowed penny-stock at an incredible P/S of 0.55 versus competitors' with P/S profiles of ~3.0. The company is underfollowed and experienced an unjustified sell-off due to short-term headwinds (COVID...
Surgalign Holdings, Inc. (SRGA) Q2 2021 Earnings Conference Call August 06, 2021, 09:00 AM ET Company Participants Terry Rich - President and CEO Jon Singer - Chief Financial and Operating Officer Kris Siemionow - Chief Medical Officer. Conference Call Participants Matt Hewitt - Craig-Hallum ...